1,1'-[Carbonylbis(oxy)]bis(1H-benzotriazole)(CAS: 88544-01-8)

1,1'-[Carbonylbis(oxy)]bis(1H-benzotriazole) (CAS: 88544-01-8) falls under various regulatory guidelines. Under GHS, it is classified as a sensitiser. REACH regulations in the EU require registration for substances above 1 tonne per annum. FDA regulations concerning the use of this compound in pharmaceuticals are stringent, requiring compliance with good manufacturing practices (GMP). EPA regulations in the US focus on safe handling, storage, and disposal to prevent environmental contamination.

Several alternatives to 1,1'-[Carbonylbis(oxy)]bis(1H-benzotriazole) (CAS: 88544-01-8) exist in synthesis, including 1H-benzotriazole-1-carboxylic acid, 5-(4,4-dimethyl-3-oxobutyl), and 1,1'-azobis(1,1-cyclohexanediol). These alternatives offer similar reactivity but with varying advantages in terms of solubility and efficiency, making them viable substitutes depending on the specific application.

The market for 1,1'-[Carbonylbis(oxy)]bis(1H-benzotriazole) (CAS: 88544-01-8) is driven by its extensive use in pharmaceuticals, adhesives, and coatings. Research trends indicate a focus on developing more sustainable and eco-friendly alternatives. Emerging studies explore its applications in nanotechnology and as a crosslinker in polymer chemistry, reflecting a growing interest in its versatile properties.

Waste containing 1,1'-[Carbonylbis(oxy)]bis(1H-benzotriazole) (CAS: 88544-01-8) should be collected in appropriate containers and stored in a secure area. Incineration is a common method, provided it meets environmental standards. For safer disposal, professional waste treatment facilities are recommended. Strict adherence to local and international environmental regulations is crucial to prevent contamination and ensure safety during waste management.